SCHEMBL3102141

SCHEMBL3102141

O=C(CCc1ccccc1)CC(O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.65
TRPV1 Q8NER1 2/20 0.56
KEAP1 Q14145 1/20 0.52
ALDH1A1 P00352 1/20 0.48
FFAR1 O14842 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HDAC2 Q92769 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
MMP12 P39900 1/20 0.45
HDAC3 O15379 1/20 0.44
MAPK1 P28482 1/20 0.44
ADRA1A P35348 1/20 0.44
HDAC4 P56524 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HDAC1 Q13547 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3091093 0.90 TRPA1 (0.55) TRPA1TRPV1TDP1HDAC2HDAC8
SCHEMBL30248263 0.88 TRPA1 (0.57) TRPA1TRPV1HDAC2HDAC8HDAC6
SCHEMBL9061130 0.82 LMNA (0.54) L3MBTL1MAPK1SMN1; SMN2
SCHEMBL3089272 0.81 CNR2 (0.49) TRPA1TDP1L3MBTL1HDAC8HDAC6
1-Hydroxy-6-(4-Hydroxy-Phenyl)-1-Phenyl-Hexan-3-One (Enantiomeric Mix) SCHEMBL3098019 0.81 TRPV1 (0.58) TRPA1TRPV1HDAC2HDAC8HDAC6
SCHEMBL19187731 0.81 TRPA1 (0.58) TRPA1TRPV1KEAP1ALDH1A1FFAR1
SCHEMBL19186967 0.81 TRPA1 (0.58) TRPA1TRPV1KEAP1ALDH1A1FFAR1
SCHEMBL25867528 0.80 TRPA1 (0.67) TRPA1TRPV1KEAP1ALDH1A1FFAR1
SCHEMBL27724984 0.80 TRPV1 (0.60) TRPA1TRPV1HDAC2HDAC1
SCHEMBL31272029 0.79 TRPA1 (0.77) TRPA1TRPV1KEAP1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249243-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY PULKKINEN JUHA 2010-09-30 US disclosed
US-20100249243-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY PULKKINEN JUHA 2010-09-30 US disclosed
US-20100249243-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY PULKKINEN JUHA 2010-09-30 US disclosed
EP-2227449-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY Pulkkinen, Juha (FI) 2010-09-15 EP disclosed
WO-2009066008-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY PULKKINEN JUHA (FI) 2009-05-28 WO disclosed
WO-2009066008-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY PULKKINEN JUHA (FI) 2009-05-28 WO disclosed
EP-1397364-A1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS ELI LILLY AND COMPANY (US) 2004-03-17 EP disclosed
WO-2002094833-A1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS ELI LILLY AND COMPANY (US) 2002-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249243-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY HSD17B11, HSD17B7, CYP19A1 TRPA1 4348/4885TRPV1 3501/4885KEAP1 654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.